Anthony S. Gibney
CIK: 0001750132
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 16, 2026AURA
Aura Biosciences, Inc.
Sale(S)Direct12.8K shares at avg. $6.42$82K - Mar 2, 2026AURA
Aura Biosciences, Inc.
Award(A)Direct71.2K shares- - Jun 2, 2025AURA
Aura Biosciences, Inc.
Award(A)Direct150K shares- - May 16, 2025AURA
Aura Biosciences, Inc.
Purchase(P)Direct50K shares at avg. $4.90$245K - May 16, 2025AURA
Aura Biosciences, Inc.
Sale(S)Direct1.5K shares at avg. $5.15$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  AURA Aura Biosciences, Inc. | Sale(S) | 12,824 | $6.42 | $82,330 | Direct |
| Mar 2, 2026 | AURA Aura Biosciences, Inc. | Award(A) | 71,245 | - | $0 | Direct |
| Jun 2, 2025 | AURA Aura Biosciences, Inc. | Award(A) | 150,000 | - | - | Direct |
| May 16, 2025 | AURA Aura Biosciences, Inc. | Purchase(P) | 50,000 | $4.90 | $245,000 | Direct |
| May 16, 2025 | AURA Aura Biosciences, Inc. | Sale(S) | 1,519 | $5.15 | $7,823 | Direct |
1-5 of 5 transactions
About Gibney Anthony S
Gibney Anthony S (SEC CIK 0001750132) files insider reports with the SEC as Officer of Aura Biosciences, Inc. (AURA) and Director of InflaRx N.V. (IFRX).
Signal8 holds 6 ownership filings by Gibney Anthony S (2 Form 3, 4 Form 4), filed between May 16, 2025 and Jun 16, 2026. Those filings report 5 transactions, from May 16, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gibney Anthony S's filings is in BOSTON, MA.
Recent filings by Gibney Anthony S
- Jun 16, 2026: Open-market sale of AURA shares (Form 4, code S).
- Mar 2, 2026: Grant or award of AURA shares (Form 4, code A).
- Jun 2, 2025: Grant or award of AURA shares (Form 4, code A).
- May 16, 2025: Open-market purchase of AURA shares (Form 4, code P).
- May 16, 2025: Open-market sale of AURA shares (Form 4, code S).
Other insiders filing for Aura Biosciences, Inc. (AURA)
- Person Julie, Chief People Officer
- Kratz Erica, Chief Reg. & Quality Officer
- Hopkins Janet Jill, Chief Medical Officer
- Elazzouzi Amy, SVP, Finance & PAO
- Abu-Absi Susan, Chief Operating Officer
- Bender Jeremy, Director